APR-246 enhances the anticancer effect of doxorubicin against p53-mutant AsPC-1 pancreatic cancer cells. Baghdad Sci.J [Internet]. 2024 Aug. 1 [cited 2025 Sep. 4];21(8):2551. Available from: https://bsj-ojs.uobaghdad.edu.iq/index.php/BSJ/article/view/10135